Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137825 · ClinicalTrials.gov registry record
Registry of Older Patients With Cancer
A clinical trial of Lymphoma and Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 7
- Study locations
NCT01137825 is a study of Lymphoma and Leukemia that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 3,000 participants, above the 474-participant average among 299 other Lymphoma trials with a reported enrollment target (533% higher). The trial reports 7 study locations across 1 state.
The verdict
NCT01137825, a study of Lymphoma and Leukemia, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.
Conditions Studied
Study Locations (7)
North Carolina
- Seby B. Jones Cancer Center - Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill - Chapel Hill
- East Carolina University - Greenville
- Pardee Cancer Center - Hendersonville
- Carteret Health Care Cancer Center - Morehead City
- Carolina East Radiology - New Bern
- Rex Healthcare - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2009-09 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01137825
The ClinicalTrials.gov registry entry for NCT01137825 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 474-participant average among 299 other Lymphoma trials with a reported enrollment target (533% higher). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Lymphoma appearing as the primary indexed condition, and to 0 interventions.
NCT01137825 reports 7 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01137825 about?
NCT01137825 is a clinical study titled "Registry of Older Patients With Cancer". RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.
What is the current status of trial NCT01137825?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2009-09. Estimated completion is 2030-12.
What conditions does trial NCT01137825 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Unspecified Adult Solid Tumor, Protocol Specific, Multiple Myeloma and Plasma Cell Neoplasm.
Who is sponsoring clinical trial NCT01137825?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01137825 being conducted?
This trial has 7 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
RECRUITING · Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.